RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma
- Pay on delivery
- We confirm your order by phone first
- Cairo & Giza: delivered the same or the next day
- Frozen gel packs with every order
- Installments through valU / Contact / Aman (the company sets the plan)
- 💳 A 2.5% card fee is added to the amount paid by Visa / Mastercard.
- 🏷️ Installments carry extra fees set by the installment company (valU, Contact or Aman), depending on the plan.
Product label & authenticity
- From the product label:
- Pre-filled pen: 40 mg retatrutide in a 3 mL cartridge
- Box: 1 pen + 8 disposable needles
- Verification QR code on the box
- Official website: msakpharma.com
- Authenticity check: MSAK states that official products have a verification QR code on the box.
Source: Product label photo · msakpharma.com/retapic · Last checked: 2026-10-22
What the published research shows
A plain-language summary of the human studies, recorded adverse events and regulatory status, with a link to every source.
RetatrutidePhase 3 human trials
A single molecule that acts on three hormone receptors at once: GLP-1 and GIP (the incretin pair also targeted by tirzepatide) plus the glucagon receptor. Researchers are studying it in obesity, type 2 diabetes and related conditions.
Human studies
- Phase 2 trial in 338 adults with obesity: researchers reported a mean body-weight change of up to −24.2% at 48 weeks in the highest-dose group, against −2.1% with placebo. NEJM 2023
- TRIUMPH-1, Phase 3, 2,339 adults over 80 weeks: Eli Lilly reported a mean change of −28.3% in the highest-dose group against −2.2% with placebo (topline results, not yet peer-reviewed). HCPLive · TRIUMPH-1
- TRIUMPH-2 (1,152 adults with type 2 diabetes) and TRIUMPH-3 (1,949 adults with cardiovascular disease) also met their main goals, according to the company. HCPLive · TRIUMPH-2/3
Adverse events recorded
- Most adverse events were gastrointestinal (nausea, diarrhoea, vomiting, constipation) and became more frequent at higher doses. In TRIUMPH-1, nausea was reported by 42.4% on the highest dose against 14.8% on placebo.
- TRIUMPH-1 also recorded abnormal skin sensation (dysesthesia) in 12.5% against 0.9%; 11.3% stopped because of adverse events, against 4.9% on placebo.
- The Phase 2 trial reported a dose-related rise in resting heart rate that peaked at 24 weeks.
This is a research summary, not dosing or medical advice. The full study protocols, including every dose group, are in the linked sources. Findings describe the material used in each trial, not any specific product on sale; any use should be decided with a doctor.
Scientific background
Source-referenced research summary from the Egypt Peptides Knowledge Hub. It is not personal medical advice.
Product Details
- 📌 Product: Retatrutide
- 📌 Brand: MSAK Pharma
- 📌 Total strength: 40 mg
- 📌 Listed concentration: 40 mg / 3 ml (as listed in the product record)
- 📌 Format: Syringe pen
- 📌 Note: Specifications are as listed by the store. No dosing, preparation or usage instructions are provided on this page.
تفاصيل المنتج
- 📌 المنتج: ريتاتروتايد (Retatrutide)
- 📌 العلامة التجارية: MSAK Pharma
- 📌 إجمالي التركيز: 40 مجم
- 📌 التركيز المدرج: 40 مجم / 3 مل (حسب سجل المنتج)
- 📌 الشكل: قلم سرنجة
- 📌 ملاحظة: المواصفات كما هي مدرجة لدى المتجر. لا تقدّم هذه الصفحة أي تعليمات جرعات أو تحضير أو استخدام.
Product Technical & Storage Data
| Compound Identifier | RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma |
| Brand & Manufacturer | MSAK Pharma |
| Form & Packaging | Pen |
| Storage Temperature | Follow the storage conditions printed on the manufacturer's label. |
| Delivery | Every order is packed with frozen gel packs that hold their cold for up to 12 hours; the arrangement and shipping cost are confirmed with you by phone. |
What does RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma contain?
According to its label: Pre-filled pen: 40 mg retatrutide in a 3 mL cartridge; Box: 1 pen + 8 disposable needles. Made by MSAK Pharma.
How is RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma stored and delivered?
Store RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma as printed on its label. We keep it cold until it ships; the order goes in an insulated cooler with frozen gel packs that hold their cold for up to 12 hours. Our couriers deliver in Cairo and Giza, and other governorates receive it by private courier or bus-station pick-up.
What is the price of RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma in Egypt?
RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma is listed at 21,000 EGP on Egypt Peptides and is currently in stock. Payment is on delivery; the shipping cost for your governorate is shown at checkout.
Questions about packaging or a specific batch?
Contact us on WhatsApp before ordering and we will answer with the information we hold for this product.
How are orders kept cold during delivery?
Every order is packed with frozen gel packs that hold their cold for up to 12 hours. Delivery timing, packaging and shipping cost are confirmed with you by phone after you order.
Can I return the product after delivery?
No. Peptide products cannot be returned after delivery, because they must be kept refrigerated and need special handling when shipped.
How much does shipping cost?
Cairo and Giza: 200 EGP by courier, delivered the same or the next day. Other governorates: pick up from the bus station for 200 EGP, or a private courier whose cost is confirmed in the order confirmation call.
What are the available payment options?
You can pay Cash on Delivery (COD), via InstaPay instant bank transfer, with Visa/Mastercard on the courier's wireless POS machine, or in monthly installments using valU, Contact, or Aman right at your doorstep.
A 2.5% card fee is added to the amount paid by Visa / Mastercard. Installments carry extra fees set by the installment company (valU, Contact or Aman), depending on the plan.
Compare all listed strengths
Strength and format as written in each listing; price per mg = listed price ÷ total mg in the listing name.
| Product | Company | Format | Strength | Price | Price per mg | Availability |
|---|---|---|---|---|---|---|
| Spectrum Retatrutide Pen 24 mg | Spectrum Pharma | Pen | 24 mg | 16,000 EGP | 667 EGP | In stock |
| ZPHC Retatrutide 30mg Vial + Bacteriostatic Water | ZPHC | Vial | 30 mg | 15,500 EGP | 517 EGP | In stock |
| ZPHC Retatrutide Pen 30 mg | ZPHC | Pen | 30 mg | 18,000 EGP | 600 EGP | In stock |
| ZPHC Retatrutide 40 mg | ZPHC | Kit | 40 mg | 19,000 EGP | 475 EGP | In stock |
| MAJIX Retatrutide 40 mg Dual-Chamber Pen | MAJIX | Pen | 40 mg | 21,000 EGP | 525 EGP | In stock |
| RetaPic 40mg (Retatrutide) Syringe Pen - MSAK Pharma (this product) | MSAK Pharma | Pen | 40 mg | 21,000 EGP | 525 EGP | In stock |
| ALLUVI Retatrutide Pen 40 mg | ALLUVI | Pen | 40 mg | 22,000 EGP | 550 EGP | In stock |
| VLS Retatrutide 40 mg Multi-Use Pen | VLS | Pen | 40 mg | 22,000 EGP | 550 EGP | In stock |
